Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P11021 (
BiP
)
2,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have recently shown that an adenovirus carrying REIC/Dkk-3 (Ad-REIC) exhibits a potent tumor-specific cell-killing function for various human cancers. It has also become evident that some human cancers are resistant to Ad-REIC-induced apoptosis. The aim of the present study was to determine the molecular mechanisms of resistance to Ad-REIC. First, we isolated resistant clones from a human prostate cancer cell line,
PC3
, after repeated exposure to Ad-REIC. Infection efficiency of the adenovirus vector and expression level of REIC/Dkk-3 in the resistant clones were similar to those in the parental
PC3
cells. By screening for alteration in levels and functional status of proteins involved in Ad-REIC-induced apoptosis, we found that
BiP
/GRP78, an ER-residing chaperone protein, was expressed at higher levels consistently among resistant cells. Expression levels of
BiP
and rates of apoptosis induced by Ad-REIC were inversely correlated. Down-regulation of
BiP
with siRNA sensitized the resistant cells to Ad-REIC in vivo as well as in culture. These results indicate that
BiP
is a major determinant of resistance to Ad-REIC-induced apoptosis. Thus
BiP
is useful for diagnosis of inherent and acquired resistance of cancers and also as a target molecule to overcome resistance to the gene therapeutic Ad-REIC.
...
PMID:Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3. 1962 90
In prostate cancer, oxidative stress and the subsequent Nrf2 activation promote the survival of cancer cells and acquired chemoresistance. Nrf2 links prostate cancer to endoplasmic reticulum stress, an event that triggers the unfolded protein response, aiming to restore cellular homeostasis as well as an adaptive survival mechanism. Glucose-regulated protein of 78 kD /
immunoglobulin heavy chain binding protein
(GRP78/
BiP
) is a key molecular chaperone in the endoplasmic reticulum that, when expressed at the cell surface, acts as a receptor for several signaling pathways enhancing antiapoptotic and proliferative signals. We showed GRP78/
BiP
translocation to
PC3
cell surface in the presence of tunicamycin, an ER stress inductor, and demonstrated the existence of a GRP78/
BiP
-dependent non-canonical Nrf2 activation, responsible for increased resistance to ER-stress induced apoptosis. We found that, even in the absence of ROS production, tunicamycin causes Nrf2 activation, and activates Akt signaling, events bulnted by anti-GRP78/
BiP
antibody treatment. The presence of GRP78/
BiP
at the cell surface might be exploited for the immunotherapeutic strategy of prostate cancer since its blockage by anti-GRP78/
BiP
antibodies might promote cancer death by suppressing some of the several molecular protective mechanisms found in aggressive cancer cells.
...
PMID:ROS-independent Nrf2 activation in prostate cancer. 2897 49